Literature DB >> 22965670

ACE inhibitors versus ARBs versus DRIs: a systematic update.

Jeff Kohlwes.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2012        PMID： 22965670      PMCID： PMC3509292          DOI： 10.1007/s11606-012-2212-4

Source DB:  PubMed          Journal:  J Gen Intern Med        ISSN： 0884-8734            Impact factor:   5.128


× No keyword cloud information.
  5 in total

Review 1.  Updated report on comparative effectiveness of ACE inhibitors, ARBs, and direct renin inhibitors for patients with essential hypertension: much more data, little new information.

Authors:  Benjamin J Powers; Remy R Coeytaux; Rowena J Dolor; Vic Hasselblad; Uptal D Patel; William S Yancy; Rebecca N Gray; R Julian Irvine; Amy S Kendrick; Gillian D Sanders
Journal:  J Gen Intern Med       Date:  2011-12-07       Impact factor: 5.128

2.  Newer is not always better: all antihypertensive medications do not equally reduce cardiovascular risk.

Authors:  Gerald W Smetana
Journal:  J Gen Intern Med       Date:  2012-06       Impact factor: 5.128

3.  Management of hypertension: summary of NICE guidance.

Authors:  Taryn Krause; Kate Lovibond; Mark Caulfield; Terry McCormack; Bryan Williams
Journal:  BMJ       Date:  2011-08-25

Review 4.  Half a century of hydrochlorothiazide: facts, fads, fiction, and follies.

Authors:  Franz H Messerli; Sripal Bangalore
Journal:  Am J Med       Date:  2011-10       Impact factor: 4.965

5.  The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure: the JNC 7 report.

Authors:  Aram V Chobanian; George L Bakris; Henry R Black; William C Cushman; Lee A Green; Joseph L Izzo; Daniel W Jones; Barry J Materson; Suzanne Oparil; Jackson T Wright; Edward J Roccella
Journal:  JAMA       Date:  2003-05-14       Impact factor: 56.272
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.